Shares of Cresco Labs (CSE:CL)(OTCQX:CRLBF) are on the rise 6.07% to press time and selling for $10.49 USD. The company announced that it received regulatory approval for its acquisition “of 100% of the membership interests of Gloucester Street Capital, LLC, the parent entity of Valley Agriceuticals, LLC via a merger between Gloucester and an indirect subsidiary of Cresco Labs”.
The news has caused shares to surge—a much-needed respite for this ailing stock that has lost over 33% since mid-June.
Cresco Labs – Damaged In Recent MonthsCresco is one of the US’s largest, multi-state, ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.